Update on pharmaceutical brand name requirements in Canada

Lexology (@lexology) | Twitter

From www.lexology.com – February 18, 2015

In an effort to standardize the brand name review process, Health Canada released a new Guidance Document for Industry – Review of Drug Brand Names, which replaces the 2013 Draft Revised Guidance Document for Industry – Review of Drug Names for Look-Alike Sound-alike (LASA) Attributes. The new Guidance will come into effect on June 13, 2015.
Sponsors filing a drug submission must also provide a brand name assessment as part of the drug safety and effectiveness evaluation.